Gocovri (amantadine) is used for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medication. It is also used as an add-on therapy in Parkinson's patients who are being treated with levodopa/carbidopa and who are experiencing "off" episodes.